Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting glutamine metabolism as a potential target for cancer treatment. | J Exp Clin Cancer Res | 2025 | 40598593 | PubTator, text mining | PubMed |
| Genome-scale knockout simulation and clustering analysis of drug-resistant breast cancer cells reveal drug sensitization targets. | Proc Natl Acad Sci U S A | 2025 | 40560621 | PubTator, text mining | PubMed |
| Identification and Analysis of Differentially Expressed Ferroptosis-Related Genes in Microtia. | J Craniofac Surg | 2025 | 40560180 | PubTator, text mining | PubMed |
| Supplementing sialic acid analogs overcomes radiotherapy resistance in triple-negative breast cancer by exacerbating ER stress. | Redox Biol | 2025 | 40505348 | PubTator, text mining | PubMed |
| Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia. | Haematologica | 2025 | 40501394 | PubTator, text mining | PubMed |
| SLC1A5 mediates myocardial damage after myocardial infarction by triggering cardiomyocyte ferroptosis. | Biochem Pharmacol | 2025 | 40490039 | PubTator, text mining | PubMed |
| PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancer. | bioRxiv | 2025 | 40475404 | PubTator, text mining | PubMed |
| Nanoarchitecting intelligently encapsulated designs for improved cancer therapy. | Front Bioeng Biotechnol | 2025 | 40375976 | PubTator, text mining | PubMed |
| Yuanhuacine suppresses head and neck cancer growth by promoting ASCT2 degradation and inhibiting glutamine uptake. | Acta Pharmacol Sin | 2025 | 40374895 | PubTator, text mining | PubMed |
| Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications. | Front Immunol | 2025 | 40370433 | PubTator, text mining | PubMed |
| Immunosuppressive Effects of Multiple Myeloma-Derived Extracellular Vesicles Through T Cell Exhaustion. | Cancer Sci | 2025 | 40344445 | PubTator, text mining | PubMed |
| Inhibition of GLS1 and ASCT2 Synergistically Enhances the Anticancer Effects in Pancreatic Cancer Cells. | J Microbiol Biotechnol | 2025 | 40223274 | PubTator, text mining | PubMed |
| The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis. | Cancer Cell Int | 2025 | 40158101 | PubTator, text mining | PubMed |
| Altered structural and transporter-related gene expression patterns in the placenta play a role in fetal demise during Porcine reproductive and respiratory syndrome virus infection. | BMC Genomics | 2025 | 40119254 | PubTator, text mining | PubMed |
| Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death. | Dev Cell | 2025 | 40086433 | PubTator, text mining | PubMed |
| HOTAIR Participation in Glycolysis and Glutaminolysis Through Lactate and Glutamate Production in Colorectal Cancer. | Cells | 2025 | 40072116 | PubTator, text mining | PubMed |
| [Integrative transcriptomics-metabolomics approach to identify metabolic pathways regulated by glutamine synthetase activity]. | Se Pu | 2025 | 40045642 | PubTator, text mining | PubMed |
| Single-cell eQTL Mapping Reveals Cell Subtype-specific Genetic Control and Mechanism in Malignant Transformation of Colorectal Cancer. | Cancer Discov | 2025 | 40029140 | PubTator, text mining | PubMed |
| IL17A/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN/ PTGS2 pathway. | Int Immunopharmacol | 2025 | 39954656 | PubTator, text mining | PubMed |
| Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells. | Pharmacol Res | 2025 | 39909124 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=10